Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.
Patrick Mooney
Advertisement
Articles by Patrick Mooney
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops
2
Exercise for the prevention and mitigation of eye disease
3
Georgia university receives state funding for state's first college of optometry
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5